EA8184

Prostate Cancer

EA8184: A Phase II Randomized Double Blinded Study of Green Tea Catechins (GTC) vs. Placebo in Men on Active Surveillance for Prostate Cancer: Modulation of Biological and Clinical Intermediate Biomarkers.

Key Team Members

Principal Investigator

T. Brian Willard, MD

Research Coordinator

Taylor Knight

Not Accepting Patients

Check if You’re Eligible

(803) 935-8300

Research@lexhealth.org

About the Trial

The purpose of this study is to find out if the study drug can help prevent progression of prostate cancer from a low risk stage to higher risk stages in men who are on active surveillance.